Moving forward with isoprostanes, neuroprostanes and phytoprostanes: where are we now?

Omar S Ahmed1,2, Jean-Marie Galano1, Tereza Pavlickova1

  • 1Institut des Biomolécules Max Mousseron (IBMM), UMR 5247 CNRS, ENSCM, Université de Montpellier, France.